Overview

Detailed Summary

Coral Laboratories Limited (CLL) is a pharmaceutical company focused on manufacturing generic branded, nutraceuticals, OTC, and herbal medicines across India.
The company operates three production facilities located in Daman and Dehradun, enhancing its manufacturing capacity and scope.
Originally promoted by Navin B Doshi of the DWD group, Coral Labs raised Rs. 2.5 crores through a public issue to expand its manufacturing capabilities.
Coral Laboratories began commercial production at its ultra-modern unit in Daman in March 2004 and its plant in Dehradun in September 2006.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 178 Cr
Volatility: Low Risk
P/E Ratio: 10.9
Industry P/E: 33.7
PEG Ratio: 0.3
P/B Ratio: 0.9
52W High: 624.95
52W Low: 360.00

Sales CAGR

1Y: 37.47%
3Y: 15.00%
5Y: 10.26%
10Y: 4.32%

Profit CAGR

1Y: 53.01%
3Y: 38.74%
5Y: 27.64%
10Y: 7.69%

ROE

TTM: 7.83%
3Y: 8.70%
5Y: 8.35%
10Y: 9.43%

ROCE

TTM: 10.89%
3Y: 11.29%
5Y: 10.74%
10Y: 12.66%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SPML		214.10	188 Cr	14.44	2.64	0.00	18.31	18.42	13.68
OXYGENTAPH		50.19	186 Cr	-10.57	0.00	0.00	41.16	-26.02	-14.69
ANL		255.10	185 Cr	36.79	6.02	0.00	14.29	16.99	12.01
SANJIVIN		149.60	181 Cr	27.02	3.75	0.00	13.87	16.29	7.62
CORALAB		502.50	177 Cr	10.83	0.85	0.00	7.83	10.89	6.81
GUJINJEC		119.90	176 Cr	96.51	14.84	0.00	15.34	21.17	4.96
QUESTLAB		101.15	166 Cr	11.04	1.71	0.00	15.51	19.06	13.51
Median: 7 Co.	—	149.60	181 Cr	14.44	2.64	0.00	15.34	16.99	7.62

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	18	29	32	32	23	28	19	19	22	26
Expenses	16	23	21	26	17	25	17	14	20	20
Operating Profit	2.10	6.25	11	6.51	6.31	2.68	2.18	4.93	1.89	6.20
OPM %	11.62	21.63	33.92	20.20	27.45	9.53	11.58	25.91	8.77	23.41
Other Income	1.37	2.00	1.56	2.54	2.52	1.71	2.05	3.03	2.49	2.64
Interest	0.00	0.00	0.03	0.01	0.02	0.04	0.06	0.10	0.00	0.01
Depreciation	0.49	0.50	0.49	0.51	0.50	0.51	0.45	0.45	0.69	0.54
Profit Before Tax	2.98	7.74	12	8.53	8.31	3.85	3.72	7.42	3.70	8.29
Tax %	27.52	25.32	25.23	25.21	26.11	26.49	31.18	21.56	24.86	36.91
Net Profit	2.16	5.79	8.80	6.38	6.14	2.83	2.56	5.82	2.78	5.22
EPS in Rs	6.04	16.20	24.64	17.86	17.20	7.91	7.18	16.29	7.77	14.62

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	95	92	91	71	97	76	78	84	115	102
Expenses	72	77	79	65	81	67	74	67	89	84
Operating Profit	23	15	12	5.29	16	8.21	3.81	16	26	18
OPM %	24.21	16.41	13.48	7.50	16.41	10.86	4.88	19.41	22.82	17.30
Other Income	3.04	4.47	5.16	5.89	3.79	5.77	6.93	6.47	8.34	8.82
Interest	0.03	0.03	0.02	0.06	0.04	0.14	0.34	0.00	0.10	0.13
Depreciation	1.56	1.56	1.90	2.01	1.98	1.99	2.18	1.98	2.01	1.97
Profit Before Tax	25	18	16	9.12	18	12	8.23	21	32	24
Tax %	33.66	31.05	34.11	21.79	23.04	23.70	21.65	23.84	25.61	26.63
Net Profit	16	12	10	7.13	14	9.05	6.45	16	24	18
EPS in Rs	45.61	34.84	28.61	19.96	37.95	25.32	18.04	44.21	67.61	45.86
Dividend Payout %	10.96	5.74	6.99	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.57	3.57	3.57	3.57	3.57	3.57	3.57	3.57	3.57	3.57
Reserves	67	106	113	110	112	133	152	151	174	198
Borrowings	0.37	2.17	1.74	1.44	5.91	6.25	6.04	0.00	0.00	3.56
Other Liabilities	19	20	22	21	23	25	28	20	28	25
Total Liabilities	89	131	140	136	144	168	190	174	206	229
Fixed Assets	18	18	22	22	22	20	23	24	23	22
CWIP	0.00	0.23	0.00	0.00	0.00	0.50	1.72	0.00	0.00	2.48
Investments	4.58	39	45	29	26	34	47	42	51	53
Other Assets	67	74	73	84	97	112	118	108	132	152
Total Assets	89	131	140	136	144	168	190	174	206	229

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	5.05	11	13	-0.88	-3.86	0.93	6.08	13	-5.46	-1.22
Cash from Investing Activity	-2.73	-9.80	-13	3.23	-1.55	-0.07	-6.05	-2.61	1.40	-0.15
Cash from Financing Activity	-0.05	0.47	-2.62	-1.18	3.56	0.35	0.15	-6.43	0.01	2.71
Net Cash Flow	2.28	1.45	-2.36	1.17	-1.86	1.21	0.18	3.62	-4.06	1.33

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%	71.51%
FIIs	0.14%	0.14%	0.14%	0.14%	0.23%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	28.35%	28.35%	28.35%	28.35%	28.26%	28.49%	28.49%	28.49%	28.49%	28.49%	28.49%	28.49%
Total Shareholders	4,040	3,981	4,005	4,098	3,831	3,949	4,054	4,105	4,213	4,286	4,208	4,084

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.